SCHEMBL6207556

SCHEMBL6207556

O=C(Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12)N(CCCN1CCC1)N(C(=O)NCCCCl)c1n[nH]c2cc(Cl)c(-c3ccccc3)cc12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 14/20 0.46
CDK1 P06493 1/20 0.46
CDK2 P24941 1/20 0.46
CYP1A2 P05177 4/20 0.39
GSK3A P49840 1/20 0.38
PRKAB2 O43741 2/20 0.35
PRKAG1 P54619 2/20 0.35
PRKAA2 P54646 2/20 0.35
PRKAA1 Q13131 2/20 0.35
PRKAG3 Q9UGI9 2/20 0.35
PRKAG2 Q9UGJ0 2/20 0.35
PRKAB1 Q9Y478 2/20 0.35
ACHE P22303 1/20 0.35
DRD2 P14416 2/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
SMYD2 Q9NRG4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207558 0.84 GSK3B (0.58) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL4500932 0.81 GSK3B (0.62) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL4492373 0.76 GSK3B (0.70) GSK3BCDK1CDK2CYP1A2PRKAB2
SCHEMBL4494753 0.76 GSK3B (0.64) GSK3BCDK1CDK2CYP1A2GSK3A
SCHEMBL1461200 0.75 GSK3B (0.61) GSK3BCDK1CDK2CYP1A2PRKAB2
SCHEMBL1461071 0.70 GSK3B (0.52) GSK3BCDK1CDK2CYP1A2ACHE
SCHEMBL1461084 0.69 GSK3B (0.66) GSK3BCDK1CDK2CYP1A2PRKAB2
SCHEMBL4492707 0.68 GSK3B (0.69) GSK3BCDK1CDK2CYP1A2PRKAB2
SCHEMBL4497559 0.68 GSK3B (0.74) GSK3BCDK1CDK2CYP1A2PRKAB2
SCHEMBL4499482 0.66 GSK3B (0.75) GSK3BCDK1CDK2CYP1A2GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537087-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2005-06-08 EP disclosed
WO-2004022544-A1 NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2004-03-18 WO disclosed